pharma operations – Page 54 – Pharma.Tips

CMC section queries unresolved during post-approval maintenance – FDA/EMA expectations and how to respond

Addressing Unresolved CMC Section Queries During Post-Approval Maintenance: Insights for Pharma Professionals In the dynamic landscape of pharmaceutical manufacturing and regulatory compliance, unresolved Chemistry, Manufacturing, and Controls (CMC) section queries…

Recurring equipment stoppages during seasonal HVAC load changes – CAPA that links maintenance to product quality risk

Addressing Recurring Equipment Stoppages Linked to Seasonal HVAC Load Changes The pharmaceutical industry often grapples with the challenge of maintaining stringent manufacturing and quality standards amidst varying operational conditions. One…

Inconsistent global strategy during lifecycle management – documentation gaps inspectors question

Addressing Inconsistent Global Strategies in Lifecycle Management: An Investigative Approach In pharmaceutical manufacturing and quality control, the alignment of lifecycle management strategies can significantly impact compliance and operational integrity. Inconsistent…

Calibration failure discovered during shutdown and restart – how to defend maintenance decisions to inspectors

Understanding Calibration Failures During Shutdown and Restart to Ensure Regulatory Compliance Calibration failures discovered during shutdown and restart can pose significant challenges for pharmaceutical manufacturers, especially in the context of…

Post-approval change misclassified during agency query response – FDA/EMA expectations and how to respond

“`html Responding to Misclassified Post-Approval Changes During Regulatory Queries In today’s fast-paced pharmaceutical landscape, maintaining compliance with regulatory bodies such as the FDA, EMA, and MHRA is paramount. One of…

Spare part not qualified during inspection walkthrough – CAPA that links maintenance to product quality risk

“`html Addressing Unqualified Spare Parts as a Quality Risk during Inspection Walkthroughs When conducting inspection walkthroughs in pharmaceutical manufacturing, the presence of unqualified spare parts can lead to significant quality…

Submission delayed due to data gaps during variation planning – documentation gaps inspectors question

Addressing Delays in Submission Due to Documentation Gaps in Variation Planning In the highly regulated pharmaceutical industry, maintaining compliance is crucial for successful product lifecycle management. A frequent issue encountered…

CMMS records incomplete during changeover maintenance – CAPA that links maintenance to product quality risk

“`html Addressing Incomplete CMMS Records During Changeover Maintenance: A Comprehensive CAPA Approach In pharmaceutical manufacturing, the integrity of equipment maintenance records is pivotal to ensuring product quality and compliance with…

Deficiency response rejected by agency during agency query response – FDA/EMA expectations and how to respond

Responding to a Rejected Deficiency Response During Agency Queries: A Comprehensive Investigation Guide In the highly regulated pharmaceutical landscape, receiving a rejection on a deficiency response from an agency such…

Spare part not qualified during routine operations – GMP documentation expectations for engineering teams

Investigating Unqualified Spare Parts During Routine Operations in Pharma Manufacturing In pharmaceutical manufacturing, the qualification of spare parts is paramount to maintaining the integrity of the processes and products. However,…

CMC section queries unresolved during lifecycle management – documentation gaps inspectors question

“`html Addressing Unresolved CMC Section Queries in Lifecycle Management: An Investigative Approach In the pharmaceutical industry, unresolved Chemistry, Manufacturing, and Controls (CMC) section queries can lead to serious compliance concerns…

Spare part not qualified during shutdown and restart – calibration/PM evidence pack checklist

Investigation into Unqualified Spare Parts During Shutdown and Restart Procedures In the pharmaceutical manufacturing environment, the qualification of spare parts during shutdown and restart procedures is critical. Failure to qualify…